Exane Derivatives’s Humana HUM Stock Holding History

Exane Derivatives’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.87K	Hold	4	–	–	﹤0.01%	447
2022 Q1	$1.74K	Hold	4	–	–	﹤0.01%	765
2021 Q4	$1.85K	Hold	4	–	–	﹤0.01%	667
2021 Q3	$1.56K	Hold	4	–	–	﹤0.01%	822
2021 Q2	$1.84K	Hold	4	–	–	﹤0.01%	823
2021 Q1	$1.68K	Hold	4	–	–	﹤0.01%	696
2020 Q4	$1.64K	Hold	4	–	–	﹤0.01%	642
2020 Q3	$1.66K	Hold	4	–	–	﹤0.01%	579
2020 Q2	$1.55K	Hold	4	–	–	﹤0.01%	521
2020 Q1	$1.26K	Hold	4	–	–	﹤0.01%	530
2019 Q4	$1.46K	Hold	4	–	–	﹤0.01%	522
2019 Q3	$1.02K	Hold	4	–	–	﹤0.01%	538
2019 Q2	$1.06K	Hold	4	–	–	﹤0.01%	556
2019 Q1	$1.06K	Sell	4 -3,205	-100%	-$924K	﹤0.01%	493
2018 Q4	$919K	Sell	3,209 -312	-9%	-$98.9K	0.16%	129
2018 Q3	$1.19M	Sell	3,521 -726	-17%	-$236K	0.22%	99
2018 Q2	$1.26M	Buy	+4,247	New	+$1.24M	0.21%	100

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Exane Derivatives's HUM Position: Q2 2022 in Review

Exane Derivatives held its Humana (HUM) position steady in Q2 2022 at 4 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #447.

Exane Derivatives first reported a position in HUM in Q2 2018 and has held it in 17 quarters since. The position peaked at $1.26M in Q2 2018. 959 funds tracked by Wall St. Rank hold HUM as of Q2 2022.

Exane Derivatives held 4 shares of Humana worth $1.87K as of Q2 2022.
Exane Derivatives left its Humana share count unchanged in Q2 2022.
Humana made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #447 holding.
Exane Derivatives first reported a position in Humana in Q2 2018 and has held it in 17 quarters since.
Exane Derivatives's Humana position peaked at $1.26M in Q2 2018.
959 funds tracked by Wall St. Rank held Humana as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.